$Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors$

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. Antitumor activity of histone deacetylase (HDAC) inhibitors in this disease has been documented, including one patient with thymoma treated with the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2011-05, Vol.29 (15), p.2052-2059
Hauptverfasser:	GIACCONE, Giuseppe, RAJAN, Arun, SPITTLER, John, LOEHRER, Patrick J, BERMAN, Arlene, KELLY, Ronan J, SZABO, Eva, LOPEZ-CHAVEZ, Ariel, TREPEL, Jane, LEE, Min-Jung, LIANG CAO, ESPINOZA-DELGADO, Igor
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Biological and medical sciences Drug Resistance, Neoplasm Female Histone Deacetylase Inhibitors - therapeutic use Humans Hydroxamic Acids - adverse effects Hydroxamic Acids - therapeutic use Male Medical sciences Middle Aged Neoplasms, Glandular and Epithelial Original Reports Pneumology Rare Recurrence Retreatment Sulfonamides Thymus Neoplasms Treatment Outcome Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!